The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Alx Oncology Holdings Inc’s stock clocked out at $1.46, up 11.88% from its previous closing price of $1.30. In other words, the price has increased by $11.88 from its previous closing price. On the day, 1.03 million shares were traded. ALXO stock price reached its highest trading level at $1.46 during the session, while it also had its lowest trading level at $1.325.
Ratios:
To gain a deeper understanding of ALXO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.82 and its Current Ratio is at 4.82. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.11.
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on December 19, 2024, Downgraded its rating to Hold and sets its target price to $2 from $12 previously.
On March 08, 2024, Stifel Downgraded its rating to Hold which previously was Buy and also upped its target price recommendation from $10 to $14.
Jefferies Upgraded its Hold to Buy on December 08, 2023, whereas the target price for the stock was revised from $8 to $18.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 06 ’25 when Pinto Shelly sold 2,221 shares for $1.80 per share. The transaction valued at 3,998 led to the insider holds 87,902 shares of the business.
Pinto Shelly sold 1,426 shares of ALXO for $2,253 on Dec 30 ’24. The Interim CFO now owns 90,123 shares after completing the transaction at $1.58 per share. On Dec 30 ’24, another insider, Pons Jaume, who serves as the PRESIDENT & CSO of the company, sold 10,796 shares for $1.58 each. As a result, the insider received 17,060 and left with 580,714 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALXO now has a Market Capitalization of 77004928 and an Enterprise Value of -54211068.
Stock Price History:
The Beta on a monthly basis for ALXO is 0.94, which has changed by -0.90670925 over the last 52 weeks, in comparison to a change of 0.22208416 over the same period for the S&P500. Over the past 52 weeks, ALXO has reached a high of $17.83, while it has fallen to a 52-week low of $1.19. The 50-Day Moving Average of the stock is -8.32%, while the 200-Day Moving Average is calculated to be -71.14%.
Shares Statistics:
It appears that ALXO traded 1.15M shares on average per day over the past three months and 1689720 shares per day over the past ten days. A total of 52.74M shares are outstanding, with a floating share count of 30.80M. Insiders hold about 41.61% of the company’s shares, while institutions hold 55.67% stake in the company. Shares short for ALXO as of 1736899200 were 7830371 with a Short Ratio of 6.81, compared to 1734048000 on 8394637. Therefore, it implies a Short% of Shares Outstanding of 7830371 and a Short% of Float of 25.729999999999997.